Inventor
ASHOK BHANDARI
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
12,552,836Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases202612,478,617Lipidated peptide inhibitors of interleukin-23 receptor202512,234,300Conjugated hepcidin mimetics202512,018,057Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases202411,939,361Compositions of peptide inhibitors of Interleukin-23 receptor202411,884,748Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases202411,845,808Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases202311,840,581a4b7 thioether peptide dimer antagonists202311,753,443Conjugated hepcidin mimetics202311,472,842Analogues of hepcidin mimetics with improved in vivo half lives2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to PROTAGONIST THERAPEUTICS INC (10)· patent assignee history
2022–2026Based in US· patent location history
2023–2025Patents assigned to JANSSEN BIOTECH INC (3)· patent assignee history
2024Patents assigned to JANSSEN PHARMACEUTICA NV (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PROTAGONIST THERAPEUTICS INC | 10 | 2022–2026 |
| JANSSEN BIOTECH INC | 3 | 2023–2025 |
| JANSSEN PHARMACEUTICA NV | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2026 |